Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 780 participants.
Also called NCT06310031
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 780 participants
- Sponsor
- BrioHealth Solutions, Inc.
- Registry
-
NCT06310031
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT06310031. Randomized; no masking; primary purpose treatment. Start 2024-10-28 (actual); primary completion 2028-02 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
- Acronym
- INNOVATE
- Condition
- Cardiovascular Diseases
- Condition
- Heart Diseases
- Condition
- Heart Failure
- Intervention (Device)
- BrioVAD System
- Intervention (Device)
- HeartMate 3
- Lead sponsor
- BrioHealth Solutions, Inc.
Record details
- Record id
cardio:ct-nct06310031- Content hash
86ef0b37cbf85d2a9b93e35e54cf11b1953ca0753a53f097f599f6be054eb997